184 related articles for article (PubMed ID: 32323826)
1. Antitumor effect of lenalidomide in malignant glioma cell lines.
Hanashima Y; Sano E; Sumi K; Ozawa Y; Yagi C; Tatsuoka J; Yoshimura S; Yamamuro S; Ueda T; Nakayama T; Hara H; Yoshino A
Oncol Rep; 2020 May; 43(5):1580-1590. PubMed ID: 32323826
[TBL] [Abstract][Full Text] [Related]
2. Anticancer effects of veratramine via the phosphatidylinositol-3-kinase/serine-threonine kinase/mechanistic target of rapamycin and its downstream signaling pathways in human glioblastoma cell lines.
Kim D; Kwon W; Park S; Kim W; Park JK; Han JE; Cho GJ; Yun S; Han SH; Kim MO; Ryoo ZY; Choi SK
Life Sci; 2022 Jan; 288():120170. PubMed ID: 34826438
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of ribavirin against malignant glioma cell lines: Follow-up study.
Ochiai Y; Sano E; Okamoto Y; Yoshimura S; Makita K; Yamamuro S; Ohta T; Ogino A; Tadakuma H; Ueda T; Nakayama T; Hara H; Yoshino A; Katayama Y
Oncol Rep; 2018 Feb; 39(2):537-544. PubMed ID: 29251333
[TBL] [Abstract][Full Text] [Related]
4. Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells.
Conti S; Vexler A; Edry-Botzer L; Kalich-Philosoph L; Corn BW; Shtraus N; Meir Y; Hagoel L; Shtabsky A; Marmor S; Earon G; Lev-Ari S
PLoS One; 2018; 13(7):e0198627. PubMed ID: 29969452
[TBL] [Abstract][Full Text] [Related]
5. IFN‑β sensitizes TRAIL‑induced apoptosis by upregulation of death receptor 5 in malignant glioma cells.
Yoshimura S; Sano E; Hanashima Y; Yamamuro S; Sumi K; Ueda T; Nakayama T; Hara H; Yoshino A; Katayama Y
Oncol Rep; 2019 Dec; 42(6):2635-2643. PubMed ID: 31638255
[TBL] [Abstract][Full Text] [Related]
6. A novel tumor-promoting role for nuclear factor IA in glioblastomas is mediated through negative regulation of p53, p21, and PAI1.
Lee JS; Xiao J; Patel P; Schade J; Wang J; Deneen B; Erdreich-Epstein A; Song HR
Neuro Oncol; 2014 Jan; 16(2):191-203. PubMed ID: 24305710
[TBL] [Abstract][Full Text] [Related]
7. 1-Oxoeudesm-11(13)-eno-12,8a-lactone induces G2/M arrest and apoptosis of human glioblastoma cells in vitro.
Liu SS; Wang YF; Ma LS; Zheng BB; Li L; Xie WD; Li X
Acta Pharmacol Sin; 2013 Feb; 34(2):271-81. PubMed ID: 23160341
[TBL] [Abstract][Full Text] [Related]
8. p53-dependent up-regulation of CDKN1A and down-regulation of CCNE2 in response to beryllium.
Gorjala P; Cairncross JG; Gary RK
Cell Prolif; 2016 Dec; 49(6):698-709. PubMed ID: 27611480
[TBL] [Abstract][Full Text] [Related]
9. Repression of Septin9 and Septin2 suppresses tumor growth of human glioblastoma cells.
Xu D; Liu A; Wang X; Chen Y; Shen Y; Tan Z; Qiu M
Cell Death Dis; 2018 May; 9(5):514. PubMed ID: 29724999
[TBL] [Abstract][Full Text] [Related]
10. Histone acetyltransferase inhibitor II induces apoptosis in glioma cell lines via the p53 signaling pathway.
Xu LX; Li ZH; Tao YF; Li RH; Fang F; Zhao H; Li G; Li YH; Wang J; Feng X; Pan J
J Exp Clin Cancer Res; 2014 Dec; 33(1):108. PubMed ID: 25523932
[TBL] [Abstract][Full Text] [Related]
11. Targeted therapy based on p53 reactivation reduces both glioblastoma cell growth and resistance to temozolomide.
Forte IM; Indovina P; Iannuzzi CA; Cirillo D; Di Marzo D; Barone D; Capone F; Pentimalli F; Giordano A
Int J Oncol; 2019 Jun; 54(6):2189-2199. PubMed ID: 31081046
[TBL] [Abstract][Full Text] [Related]
12. Roscovitine has anti-proliferative and pro-apoptotic effects on glioblastoma cell lines: A pilot study.
Kolodziej M; Goetz C; Di Fazio P; Montalbano R; Ocker M; Strik H; Quint K
Oncol Rep; 2015 Sep; 34(3):1549-56. PubMed ID: 26151768
[TBL] [Abstract][Full Text] [Related]
13. Over-expression of BMPR-IB reduces the malignancy of glioblastoma cells by upregulation of p21 and p27Kip1.
Liu S; Yin F; Fan W; Wang S; Guo XR; Zhang JN; Tian ZM; Fan M
J Exp Clin Cancer Res; 2012 May; 31(1):52. PubMed ID: 22650359
[TBL] [Abstract][Full Text] [Related]
14. Anti‑tumor effects of anti‑epileptic drugs in malignant glioma cells.
Yagi C; Tatsuoka J; Sano E; Hanashima Y; Ozawa Y; Yoshimura S; Yamamuro S; Sumi K; Hara H; Katayama Y; Yoshino A
Oncol Rep; 2022 Dec; 48(6):. PubMed ID: 36281939
[TBL] [Abstract][Full Text] [Related]
15. P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells.
Bajbouj K; Mawrin C; Hartig R; Schulze-Luehrmann J; Wilisch-Neumann A; Roessner A; Schneider-Stock R
J Neurooncol; 2012 May; 107(3):503-16. PubMed ID: 22270849
[TBL] [Abstract][Full Text] [Related]
16. CDCA7L promotes glioma proliferation by targeting CCND1 and predicts an unfavorable prognosis.
Ji QK; Ma JW; Liu RH; Li XS; Shen FZ; Huang LY; Hui L; Ma YJ; Jin BZ
Mol Med Rep; 2019 Aug; 20(2):1149-1156. PubMed ID: 31173217
[TBL] [Abstract][Full Text] [Related]
17. Enhanced sensitivity of celecoxib in human glioblastoma cells: Induction of DNA damage leading to p53-dependent G1 cell cycle arrest and autophagy.
Kang KB; Zhu C; Yong SK; Gao Q; Wong MC
Mol Cancer; 2009 Aug; 8():66. PubMed ID: 19706164
[TBL] [Abstract][Full Text] [Related]
18. Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action.
Punganuru SR; Artula V; Zhao W; Rajaei M; Deokar H; Zhang R; Buolamwini JK; Srivenugopal KS; Wang W
Cells; 2020 Jul; 9(7):. PubMed ID: 32630235
[TBL] [Abstract][Full Text] [Related]
19. Effect of As2O3 on cell cycle progression and cyclins D1 and B1 expression in two glioblastoma cell lines differing in p53 status.
Zhao S; Tsuchida T; Kawakami K; Shi C; Kawamoto K
Int J Oncol; 2002 Jul; 21(1):49-55. PubMed ID: 12063549
[TBL] [Abstract][Full Text] [Related]
20. Jaceosidin induces p53-dependent G2/M phase arrest in U87 glioblastoma cells.
Khan M; Rasul A; Yi F; Zhong L; Ma T
Asian Pac J Cancer Prev; 2011; 12(12):3235-8. PubMed ID: 22471459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
